[Experimental analysis of the interactions between heparin and a duodenal heparinoid].
It is shown that positive synergism exists between the clarifying, hypocholesterolaemising, hypolipidaemising and fibrinolytic effects of heparin sodium and a duodenal heparinoid. The results of pharmacokinetic and chemicophysical investigations are also presented.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology*; D006496:Heparinoids / Q000494:pharmacology*; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*; D010743:Phospholipids / Q000097:blood; D051381:Rats; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D005230:Fatty Acids, Nonesterified; D005343:Fibrinolytic Agents; D006496:Heparinoids; D000960:Hypolipidemic Agents; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol
Analisi sperimentale delle interazioni tra l'eparina e un eparinoide duodenale